Medicine and Health Sciences Commons^™

Development Of Novel Anticancer Agents Targeting Glioblastoma, Kate Byrne

Theses

Glioblastoma (GBM) is the most common and aggressive malignant grade IV brain tumour. It remains an incurable disease whereby the median survival rate is 15 months and 5.5 % of all patients survive five years post diagnosis. The current therapeutic strategies include the use of maximal safe surgical resection, radiotherapy, and the use of the gold standard chemotherapeutic, Temozolomide (TMZ), which is referred to as the “Stupp Protocol”. Earlier research identified two compounds, which are structurally different but exhibit a similar biological effect to Metformin, the first in-line treatment for type II diabetes. Combining drugs which target cell metabolism such …